APTO(Delisted)
Aptose BiosciencesยทNASDAQ
--
--(--)
APTO Profile
Aptose Biosciences Inc.
A clinical- stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies
251 Consumers Road, Suite 1105, Toronto, Ontario, Canada M2J 4R3
--
Aptose Biosciences Inc., was incorporated on September 5, 1986 under the Business Companies Act as RML Medical Laboratories Inc. On September 2, 2014, the company changed its name to Aptose Biosciences Inc.. Aptose Biosciences Inc. is a science-oriented clinical-stage biotechnology company dedicated to precision medicine to meet the unmet clinical needs of oncology, with an initial focus on hematology. The company's small molecule cancer treatment product line includes products designed to provide single drug efficacy and enhance the efficacy of other anticancer therapies and regimens without overlapping toxicity.
